Karim Haddad retweeted
How did pneumonitis go from a major worry to a success story with T-DXd?
Dr. Seth Wander tells Dr. Paolo Tarantino (@PTarantinoMD) how the original phase 2 data in treatment-refractory HER2-positive breast cancer showed higher rates of higher-grade pneumonitis.
Clinicians then started anticipating it. Through the phase 3 data in the second line, and now in the adjuvant and first-line settings, the grades of pneumonitis have shifted lower. The reason is vigilance: clinicians know it can happen, so they watch for it on CT and intervene before any clinical symptoms or problems with oxygenation.
He calls it a huge success story, though pneumonitis still happens and close CT monitoring is key.
🎥 Watch the full conversation: communityhealth.media/tdxd-h…
💬 How often do you image patients on T-DXd to catch ILD early?
Karim Haddad retweeted
The end of #CervicalCancer is in sight. We have the tools to eliminate it: HPV vaccination, screening and timely treatment.
Six years ago, @WHO Member States adopted a global strategy with ambitious targets: 90% HPV vaccination, 70% screening and 90% access to treatment.
Since then, vaccine supply has improved, 166 countries have introduced HPV vaccination, and a simplified single-dose schedule has made it easier and more affordable to reach girls. HPV testing and treatment are also expanding.
On #WorldCervicalCancerEliminationDay, Dr Princess Nono Simelela, my colleagues and I have a simple message:
The tools exist. The strategy is clear. The momentum is real.
Cervical cancer elimination is within our reach. With science, solidarity and sustained commitment, we can make it a reality.
telegraph.co.uk/global-healt…
#Cardiothoracic residents can apply to receive funding for valvular heart disease, mesothelioma and lung cancer, and AI and data science research through an AATS Foundation Fall Award. Submissions are due in two weeks. Apply by December 1: hubs.la/Q04Fqr_r0
Karim Haddad retweeted
The new issue of #ScienceSignaling has arrived!
New experiments may explain how drinking alcohol weakens the tumor-killing capabilities of cancer immunotherapy, a large dataset teases out tissue-specific responses to therapeutic interferons, and more. scim.ag/4C8nJEu
Karim Haddad retweeted
A new @ScienceAdvances analysis identifies a set of environmental exposures that have an outsized impact on early life. scim.ag/4C15eSq
Karim Haddad retweeted
New in Nature Cancer: CAR-T cells with a radiation-inducible promoter, so TNF is released only where the beam goes. High TNF in the tumor, none in serum.
doi.org/10.1038/s43018-026-0…
I was lucky to be part of this team. I learned a great deal from them and it was a valuable time for me.
CAR-T plus RT is still not a familiar combination in our field, but I think it could become another weapon for rad onc. We already know RT has systemic effects, immune mediated but hard to predict. This is a different trigger: the beam switches on a gene in a cell we built. Putting dose exactly where we want it is the one thing we are good at. This is one way to use that precision for something other than local control.
Congrats to Elham, Ainhoa and @rweichselbaum. Years of work finally landed. Always rooting for what comes out of that lab next, and I will be waiting for it.
Karim Haddad retweeted
Peer reviews are awash in AI-generated feedback, and disclosure policies aren’t working. Jessica Hullman argues peer review needs centralized AI checks, reviewer accountability, and desk rejects for AI slop statmodeling.stat.columbia.e…
Karim Haddad retweeted
"Global Security requires health security, which not only includes domestic readiness, but also global cooperation that should not be dependent on political winds," writes Seth Berkley in a new #ScienceExpertVoices article. scim.ag/4zhBiyA
Karim Haddad retweeted
New guidelines, ongoing gap: Despite recommendations supporting statin use in CKD, treatment remains underused, especially in advanced disease. This #researchletter in #ASNCJASN highlights a risk-treatment paradox and opportunities to improve cardiovascular prevention in CKD. kidney.pub/CJASN1218
Karim Haddad retweeted
.@WHO’s credibility rests on the quality of our science. Our scientific integrity matters more than our income.
Nine years ago, we made science leadership a priority in WHO's transformation, establishing the Science Division and Science Council.
At today's Science Council meeting, I reaffirmed our commitment to stand by the evidence, even when it comes at a financial cost.
As science moves to the forefront of health diplomacy, WHO must not only keep pace with scientific advances, but anticipate and shape them, build trust and ensure evidence serves those who need it most.
My thanks to Professor Thomas Südhof for agreeing to chair the Council and Dr Jeanine Condo for serving as the Vice-chair.
Just published in ctRO, Clinical and Translational Radiation Oncology:
ESTRO #guideline on #radiotherapy in Merkel cell #carcinoma
👉 bit.ly/48lus0i
#Radonc #SkinCancer
Karim Haddad retweeted
Academic research depends on public funds, generally obtained through competitive applications.
In this ecrLife blog, Luigi Capoani uses European case studies to weigh up the strengths and limitations of competitive funding.
bit.ly/4Aw6Vpm
Dismissing patients over supplements is bad practice, I don't know a single colleague who does it. Crediting ivermectin with a remission with zero trial evidence is worse. Spontaneous responses happen. One screenshot is not data #clinicaltrials
unavailable
25
Really nice characterization work 2-keto-D-glucose, furaldehyde, methylglyoxal & acetaldehyde identified under gas plasma treatment methylglyoxal the standout given its established anticancer activity solid groundwork for #PlasmaMedicine
This study characterized glucose oxidation products formed under gas plasma treatment across biomedically relevant glucose levels. Identified products included 2-keto-D-glucose, furaldehyde, methylglyoxal & acetaldehyde 🧪🔬 #GlucoseOxidation #GasPlasma
mdpi.com/2227-9059/13/11/283…
8
Karim Haddad retweeted
Blood cells don't fossilize very easily. Most break down shortly after death, and certain minerals can mimic the blobby shape of cells under a microscope, making the prospect of finding convincing traces of very ancient blood—say, as old as dinosaurs—far-fetched.
Yet that's what scientists say they've uncovered. With multiple lines of evidence, the international team behind the new study claims the remains from a 115-year-old dinosaur from Brazil contain the oldest fossilized red blood cells ever discovered. But some experts remain skeptical.
Learn more: scim.ag/4eYu1wq @NewsfromScience
Karim Haddad retweeted
FDA clears third renal indication for Roche's Gazyva, this time in primary membranous nephropathy $RHHBY firstwordpharma.com/story/84…
Karim Haddad retweeted
Honored to present our approach to robotic simultaneous kidney-pancreas transplantation at this Wednesday's ASTS Surgical Skills Webinar, with Dr. Mario Spaggiari and @DocWak as panelists.
Please join us:
members.asts.org/Events/even…
@ASTSChimera @amjtransplant
Karim Haddad retweeted
Updated meta-analysis of B-cell therapies in IgAN at @ISGDtweets CTS:
- 50% 🔽 proteinuria
- HR 0.16 (95% CI 0.08-0.30) for ≥40% eGFR decline or kidney failure
- No increased risk of infections (overall or serious)
In press in at Nature Medicine, PPT at CLARITY-IgAN.org
So GOOD to see this meeting underway. Prof Guiseppi-Elie's plenary frames the electroconductive hydrogel question well - looking forward to the session summaries #BIOENG2026
💥BIOENG 2026 is underway!
⚡What can we build when hydrogels conduct electricity?
📢The Conference Chair Prof. Dr. Anthony Guiseppi-Elie explored that question in his plenary.
Join the discussion on the future of bioengineering.
#MDPI #Conferences
#BIOENG2026 #Bioengineering
24
As a radiation oncologist, I can confirm no randomized trial supports ivermectin or fenbendazole in cancer. Case reports are hypothesis-generating, never dosing guidance. The harm is patients delaying proven treatment. #clinicaltrials
🚨 SAVE THIS CHART—YOUR COMPLETE QUICK REFERENCE!
💊 Ivermectin
• Low → Medium → High → Very High
• Dose ranges + frequency + timing
💊 Fenbendazole
• Multiple dosage levels for easy comparison
📌 Everything at a glance in one chart—simple, organized & easy to reference!
2
2
55









































